Welcoming Dr. Sean Wharton to our Global Obesity Advisory Board
- Megha Poddar
- May 21
- 2 min read
At nymble, we believe that tackling obesity requires more than medication—it calls for empathy, equity, and a deep understanding of the science and lived experience of those navigating this complex disease - a message pioneered by the newest member of our Global Obesity Advisory Board - Dr. Sean Wharton.
A Leader in Evidence-Based, Compassionate Care
Dr. Wharton is one of Canada’s most respected voices in obesity medicine. He holds a PhD in pharmacology and is an internal medicine specialist. As medical director of the Wharton Medical Clinic, he leads a multidisciplinary team focused on evidence-based obesity treatment. He has been a leading voice in advancing the field of obesity medicine, spearheading numerous pivotal trials in obesity pharmacotherapy as well as real-world evidence studies.
Dr.Wharton is the co-lead author of Canada’s Adult Obesity Clinical Practice Guidelines, celebrated globally for focusing on patient centered care. His work extends beyond the clinic— what truly sets Dr. Wharton apart is his focus on compassionate, patient-centered care.
Centering Equity and Empathy
Dr. Wharton has consistently challenged the stigma that surrounds obesity, advocating for a chronic disease model that treats patients with dignity and respect. His work emphasizes that real progress begins when individuals feel supported—not blamed—for their health challenges.
He’s also been a powerful advocate for addressing disparities in care, particularly for people living with obesity in marginalized communities, including the Black community in North America. His leadership continues to shine a light on the systemic biases that often prevent people from receiving appropriate care—and on the need to change that.
A Shared Mission
At nymble, we’re building a clinically-curated, AI-powered companion that guides individuals through their treatment journey—helping them manage side effects, stay informed, and feel empowered to succeed. Dr. Wharton’s values deeply align with ours: science-backed, stigma-free, and centered on the patient.
As we prepare to launch and scale our platform in 2025, his guidance will be critical in ensuring our tools are not only clinically sound but deeply human.
Please join us in welcoming Dr. Sean Wharton to nymble health. We’re honoured to work alongside a leader who brings not just expertise—but heart—to everything he does.
Read our blog to learn more about our other Global Obesity Advisory Board members.
